Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 10Neoplasms 9Marijuana Abuse 5Cancer Pain 5Glioblastoma 2Squamous Cell Carcinoma of Head and Neck 1Signs and Symptoms 1Recurrence 1Parasomnias 1Pancreatic Neoplasms 1Neuralgia 1Nausea 1Multiple Sclerosis 1Mouth Neoplasms 1Marijuana Use 1Diabetes Mellitus 1Chronic Pain 1Cachexia 1Breast Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anorexia 1Advanced Malignant Solid Tumor 1Advanced Cancer 11- Cancer Patients During Chemotherapy Treatment 1

Interventions

Megestrol Acetate 11Mirtazapine 5Olanzapine 4anamorelin 2Infliximab 2nabiximols 1nabilone 1Watchful Waiting 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Quality of Life 1Palonosetron 1Observation 1Nicotine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Flurandrenolone 1Etanercept 1Eicosapentaenoic Acid 1EOM613 1Dronabinol 1Docetaxel 1Dexamethasone 1Creatine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anorexia × nabiximols × Clear all
NCT03245658 2023-12-18

The Effect of Cannabis in Pancreatic Cancer

University of Copenhagen

Phase 2 Withdrawn
Gastrointestinal

Anorexia, Cachexia, Marijuana Abuse, Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡